Who is a good candidate for this immunotherapy?
Ideal candidates include patients with certain advanced cancers—such as non-small cell lung cancer, Hodgkin lymphoma, or hepatocellular carcinoma—that have not responded to conventional treatments. Contraindications include active autoimmune diseases, severe organ dysfunction, or a history of organ transplantation. A thorough oncology evaluation is required to confirm eligibility.